Vyhledat publikace
Šlachtová, V.; Casaretto, N.; Brulíková, L.; Six, Y.*
Bicyclic N-dihalocyclopropylamide derivatives as precursors of nitrogen-containing fused polycyclic systems
Org. Biomol. Chem. 2023, 21 (31), 6325-6341. DOI: 10.1039/D3OB00643C
Chasák, J.; Oorts, L.; Dak, M.; Šlachtová, V.; Bazgier, V.; Berka, K.; De Vooght, L.; Smiejkowska, N.; Van Calster, K.; Van Moll, L.; Cappoen, D.; Cos, P.; Brulíková, L.*
Expanding the squaramide library as mycobacterial ATP synthase inhibitors: innovative synthetic pathway and biological evaluation
Bioorg. Med. Chem. 2023, 95 (-), 117504(1-18). DOI: 10.1016/j.bmc.2023.117504
Dak, M.; Šlachtová, V.; Šebela, M.; Bazgier, V.; Berka, K.; Smiejkowska, N.; Oorts, L.; Cappoen, D.; Brulíková, L.*
Novel heterocyclic hydroxamates as inhibitors of the mycobacterial zinc metalloprotease Zmp1 to probe its mechanism of function
Eur. J. Med. Chem. 2022, 244 (-), 114831 (1-15). DOI: 10.1016/j.ejmech.2022.114831
Brulíková, L.; Chasák, J.; Dak, M.; Šlachtová, V.; Cappoen, D.; Šebela, M.; Berka, K.; Bazgier, V.
New agents for the treatment of drug-resistant Mycobacterium tubercculosis
74. sjezd českých a slovenských chemických společností, September 4 – 7, 2022, Olomouc, přednáška .
Dak, M.; Šlachtová, V.; Šebela, M.; Bazgier, V.; Berka, K.; Smiejkowska, N.; Oorts, L.; Cappoen, D.; Brulíková, L.
Novel heterocyclic hydroxamates as inhibitors of the mycobacterial zinc metalloprotease Zmp1
56th Advances in Organic, Bioorganic and Pharmaceutical Chemistry, November 10 – 12, 2022, Špindlerův mlýn, poster .
Chasák, J.; Šlachtová, V.; Urban, M.; Brulíková, L.*
Squaric acid analogues in medicinal chemistry
Eur. J. Med. Chem. 2021, 209 (-), 112872 (1-23). DOI: 10.1016/j.ejmech.2020.112872
Urban, M.; Šlachtová, V.; Brulíková, L.*
Small organic molecules targeting the energy metabolism of Mycobacterium tuberculosis
Eur. J. Med. Chem. 2021, 212 (-), 113139 (1-17). DOI: 10.1016/j.ejmech.2020.113139
Šlachtová, V.; Dak, M.; Šebela, M.; Cappoen, D.; Berka, K; Bazgier, V.; Brulíková, L.
Synthesis of novel potential mycobacterial Zmp1 inhibitors
56th International Conference on Medicinal Chemistry, July 7 – 9, 2021, virtual event, poster .
Šlachtová, V.; Šebela, M.; Torfs, E.; Oorts, L.; Cappoen, D.; Berka, K.; Bazgier, V.; Brulíková, L.*
Novel thiazolidinedione-hydroxamates as inhibitors of Mycobacterium tuberculosis virulence factor Zmp1
Eur. J. Med. Chem. 2020, 185 (-), 111812 (1-13). DOI: 10.1016/j.ejmech.2019.111812
Šlachtová, V.; Janovská, L.; Brulíková, L.*
Solid phase synthesis of new thiazolidinedione-pyrimidine conjugates and their antibacterial properties
J. Mol. Struct. 2019, 1183 (-), 182-189. DOI: 10.1016/j.molstruc.2019.01.073